News und Analysen
Wall Street Thinks This Stock Will Only Rise 12%: Here's Why It Could Jump a Lot More
In many cases, analysts are guilty of being overly optimistic about the near-term prospects of the stocks they cover. But sometimes they err in a completely opposite way.
Vertex Pharmaceuticals
Wall Street Thinks This Stock Will Only Rise 12%: Here's Why It Could Jump a Lot More
In many cases, analysts are guilty of being overly optimistic about the near-term prospects of the stocks they cover. But sometimes they err in a completely opposite way.
Vertex Pharmaceuticals
Wall Street Thinks This Stock Will Only Rise 12%: Here's Why It Could Jump a Lot More
In many cases, analysts are guilty of being overly optimistic about the near-term prospects of the stocks they cover. But sometimes they err in a completely opposite way.
Vertex Pharmaceuticals
Investing $43 in This Stock per Week for 5 Years Could Give You $500 in Annual Dividend Income
If you're thinking of investing in Pfizer (NYSE: PFE) to generate some passive income from your portfolio, you won't need to spend very much to do so, provided that you're willing to play the long
Investing $43 in This Stock per Week for 5 Years Could Give You $500 in Annual Dividend Income
If you're thinking of investing in Pfizer (NYSE: PFE) to generate some passive income from your portfolio, you won't need to spend very much to do so, provided that you're willing to play the long
3 No-Brainer Stocks to Buy for Under $100 Right Now
You don't need much money to get started investing. And stocks with relatively low share prices have tremendous growth prospects.
Three Fool.com contributors identified no-brainer healthcare stocks
3 No-Brainer Stocks to Buy for Under $100 Right Now
You don't need much money to get started investing. And stocks with relatively low share prices have tremendous growth prospects.
Three Fool.com contributors identified no-brainer healthcare stocks
Why Medtronic Stock Sank Today
A blast of analyst price target cuts hit Medtronic (NYSE: MDT) stock on Friday, one trading session after the company published its latest set of quarterly earnings. Both the market and several
2 No-Brainer Stocks to Buy Right Now for Less than $30
Affordably priced shares -- typically seen as those trading under $30 on a per-share basis -- are a rarity among large companies with stable long-term growth prospects. That's because the market
2 No-Brainer Stocks to Buy Right Now for Less than $30
Affordably priced shares -- typically seen as those trading under $30 on a per-share basis -- are a rarity among large companies with stable long-term growth prospects. That's because the market
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
OSE Immunotherapeutics (OSE): Re-initiation – Milestones anticipated throughout FY23
Why Pfizer Stock Slipped by 2% Today
On the surface, Pfizer (NYSE: PFE) had some good news to report on Thursday. But investors viewed the positive as a negative, in light of its timing. This wasn't helped by an analyst's price-target
Why Pfizer Stock Slipped by 2% Today
On the surface, Pfizer (NYSE: PFE) had some good news to report on Thursday. But investors viewed the positive as a negative, in light of its timing. This wasn't helped by an analyst's price-target
Medtronic (MDT) Q4 2023 Earnings Call Transcript
Image source: The Motley Fool.
Medtronic (NYSE: MDT)Q4 2023 Earnings CallMay 25, 2023, 8:00 a.m. ET
Ryan Weispfenning
Source Fool.com
Wall Street Expects These Stocks to Soar 175% and 545%. Should You Buy?
Wall Street has high hopes for certain stocks over the coming 12 months. Two of them are biotech companies that took center stage during earlier days of the pandemic. I'm talking about Novavax
Can Pfizer Stock Double Your Money in 3 Years?
Pfizer (NYSE: PFE) has been a losing play for investors over the past 12 months. To wit: The drugmaker's stock has fallen by a whopping 28.8% over this period. Part of that decline has been driven
Can Pfizer Stock Double Your Money in 3 Years?
Pfizer (NYSE: PFE) has been a losing play for investors over the past 12 months. To wit: The drugmaker's stock has fallen by a whopping 28.8% over this period. Part of that decline has been driven
Why Medtronic Stock Is Sinking Today
Shares of the medical device maker Medtronic (NYSE: MDT) were down by 5% on heavy volume as of 10:53 a.m. ET Thursday. The big loss came after the company reported its 2023 fourth-quarter results
2 Dividend Kings on Sale That Are Yielding More Than 4%
Dividend Kings have excellent track records for dividend growth, and are often seen as some of the safest income investments to own. Two dividend growth stocks that may look tempting and that
Got $5,000? These 3 Industry Stalwarts Are Trading Near Their 52-Week Lows
A good way to diversify your portfolio is to invest in companies in different industries. And if you want to minimize your risk, a good option is to consider investing in industry leaders. Their
Got $5,000? These 3 Industry Stalwarts Are Trading Near Their 52-Week Lows
A good way to diversify your portfolio is to invest in companies in different industries. And if you want to minimize your risk, a good option is to consider investing in industry leaders. Their
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Why Shares of Organogenesis Climbed Wednesday
Shares of Organogenesis (NASDAQ: ORGO) were up 15.4% Wednesday afternoon after being up as much as 21.2% Wednesday morning. The healthcare company sells advanced wound care products for surgical and
Why Shares of Sarepta Therapeutics Are Dropping Wednesday
Shares of Sarepta Therapeutics (NASDAQ: SRPT), which focuses on genetic treatments for rare diseases, were down 11.5% Wednesday afternoon after the Food and Drug Administration (FDA) pushed back its